chrisvoncsefalvay/vaers-outcomes huggingface dataset:
6 hours after receiving 2nd dose, develped a fever (99.8), dizziness, chest tightness (lungs felt constricted), trouble breathing, coughing, and very fast heartbeat. Took Tylenol, the next day fever was gone but chest tightness and cough persisted.  On 5/11/21 checked into Urgent Care facility because fast heartbeat and chest tightness did not subside. Dr. checked my pulse (at 99 beats) and gave me a PCR test for Covid.  Coved test came back negative. On 5/16/21 at 1:00am, chest tightness felt like it was getting worse. Checked into Urgent Care ficility again. Dr. took a check x-ray and EKG. Both came back normal with nothing unusual found. Dr. prescribed Zithromax and Prednisone in case of bacterial infection and the Sterol to help with my breathing.
1 mo after KINRIX inj given, father reports a bruise type area on (L) arm. Was red initially x 24 hrs. then bruise like shadow remains now 7 mo post inj.
Pt had pain all over, not just at the injection site. Areas of the most pain were localized to weak areas and places of prior surgical procedures. Pt was fatigued and slept for 19 hours straight. She described it as an aching pain that was 7/10 or 8/10 on a pain scale. She took acetaminophen and rested until she felt better about 2 days later. Had to miss 2 days of work.
Palpitations Fasciculations Paresthesia/Neuropathy. Pt referred to cardiologist and two neurologists Later In April 2023, I will ask pt to sign release of information and forward specialist notes.
Shaking chills, fever to 102 over night#1, onset of cough about 30 hrs after vaccine was administered.   Body aches for 18 hours...onset about 12 hours after dosage given. Shaking chills and on set of 102 fever about 8 hours after dosage Continuing body aches x 36 hours Immunologist RX'd medrol pack to bring immune response under control.  Body aches started improving about 3 hours after Medrol first 3 tab dose
Had fever to 102.7 after 4 month immunizations (DTAP, IPV, HIB, PCV-7) with chills, lasted about 36 hours.  Occurred about 4-6 hours after immunizations.
Patient had Moderna covid-19 vaccine as first dose but was given pfizer mistakenly at appointment for second dose.
One week after immunizations, patient developed a low-grade fever (100.3 deg) - then patient felt warm and suddenly had a one-minute generalized tonic-clonic seizure. Paramedics arrived - patient had fever >101 deg and was post-ictal. seen in local ED, discharged home.
low grade fever; blurred vision, not able to read; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (low grade fever) and VISION BLURRED (blurred vision, not able to read) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031m20a) for COVID-19 vaccination.     The patient's past medical history included Blood pressure abnormal. Concurrent medical conditions included Nasal allergy. Concomitant products included LISINOPRIL for Blood pressure abnormal.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced PYREXIA (low grade fever) and VISION BLURRED (blurred vision, not able to read). In March 2021, PYREXIA (low grade fever) and VISION BLURRED (blurred vision, not able to read) had resolved. Not Provided          The patient's medical history and relevant concomitant medications weren't reported Treatment information was not provided; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-080441:friends case
Local reaction (L) lower thigh. Pink red spot 5 x 8 in - mild induration at center slight warm to touch.
patient tought patient was going to die the last time patient took it; Took flu shot twice. Sick as a dog and will never take again; Initial information was received on 11-Dec-2020 regarding an unsolicited valid non-serious case from a non-health care professional/consumer (patient) via social media.  This case involves a patient of unknown age who thought patient was going to die the last time patient took it (feeling abnormal) and took flu shot twice. Sick as a dog and will never take again (illness), while patient was treated with influenza vaccine.  Medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medication was not reported.  On an unknown date, the patient received influenza vaccine [lot number: unknown and expiration date: unknown] at an unknown dose via an unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date, (latency: unknown) after starting the suspect vaccine therapy, thought patient was going to die the last time patient took it (feeling abnormal) and took flu shot twice. Sick as a dog and will never take again (illness).  No laboratory data was reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the events was unknown.  There will be no information available regarding batch number in this case.
Pt c/o dizziness, headache, difficulty breathing, OxSat 99%, HR 107-109, dropped 75-79.  Fire department took over care
Reported vomiting about 5-10 hours after vaccine was given. Has a area of erythema and warmth 7cmx4 cm around injection site area. advised to take Benadryl and to use cool compresses.
Joint stiffness and vasculitis development after time. Tx. IV hydration and analgesia.
date of first vaccine 01/12/2021 date of second vaccine 02/20/2021  On the 7th of August, patient was having upper respiratory type symptoms. COVID PCR revealed that he was COVID positive. patient admitted 08/19/2021 with thromboembolism and COVID pneumonia.
Expired Kinrix Administered; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 4-year-old female patient who received DTPa-IPV (Kinrix) (batch number 7P5J5, expiry date 30th September 2022) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 3rd October 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 3rd October 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 07-Oct-2022 Reporter's comment: A health care professional reported that the patient received a 3 days expired dose of Kinrix. The reporter consented to follow up. Additional Supportive Information: The patient was administered an expired dose of Kinrix, which led to expired vaccine used.
Achy; he feels like he is getting the Covid-19 again; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Achy) and MALAISE (he feels like he is getting the Covid-19 again) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced PAIN (Achy) and MALAISE (he feels like he is getting the Covid-19 again). At the time of the report, PAIN (Achy) and MALAISE (he feels like he is getting the Covid-19 again) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Patient reported via email to me on 11/15/14-that "24 hours after getting flu vax, she began w/migraines." "48 hours after flu vax, she began w/full body aches and fever 100.8 and extreme weakness." "Symptoms lasted 36 hours approx."
Impression: has always had regular menstrual cycles, after Moderna #1 had 30 days of vaginal bleeding, heavy at onset and has decreased over time, found to be anemic with +symptomatic.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Hypotension-Medium, Systemic: Tingling (specify: facial area, extemities)-Mild, Systemic: Visual Changes/Disturbances-Medium, Systemic: Weakness-Mild, Additional Details: tingling in hands. vision went black.
This spontaneous report was received from a Registered Nurse and refers to a patient of an unknown age and gender. The patient's concurrent conditions, medical history, historical drugs and concomitant therapies were not reported. On an unspecified date in 2016, the patient was inadvertently vaccinated an expired dose of M-M-R II (dose, route, lot number and expiration date were not reported) for prophylaxis. On 09-AUG-2018, the patient returned to be vaccinated with another dose of M-M-R II (dose, route, lot number and expiration date were not reported) for prophylaxis. No adverse effects reported. This is one of two reports received from the same source. Sender's Comments: US-009507513-1808USA004943.
third dose of this vaccine; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (completed the Shingrix series back in 2019).   On an unknown date, the patient received the 3rd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced extra dose administered (Verbatim: third dose of this vaccine).  The outcome of the extra dose administered was unknown.   Additional Information: GSK Receipt Date: 20-SEP-2023 The HCP (healthcare professional) was not aware of lot number, or exact date of administration, since administration occurred in a facility unknown to the HCP. The patient received the 3rd dose of Shingrix which led to extra dose administered. The reporter consented to follow up.
pt recv vax 15FEB96 & 18APR96 pt devel a vesiculopapular rash w/about 50 1-2mm lesions on extremities, trunk, face & scalp, which was typical of early-onset clinical varicella;pt also exp a fever of  102;19APR96 pt irritable;20APR96 to MD;
Rec MMR 5-8-15; 5/9/15 experienced nausea, dizziness, pain at inj. site, felt warm. 5-18-15 c/o inc. nausea, loose stools, chills. Also, c/o pain prior to and at end of urination. Still sl. tender/red inj. site.
A 31 month old  was given QUADRACEL in error with no adverse event; Initial information regarding this valid unsolicited non-serious case was received from other healthcare professional on 02-Oct-2020 via Medical Information (Reference number- 00298711).  This case involved a 31-month-old patient who received a dose of DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE [QUADRACEL] in error (Product administered to patient of inappropriate age).  The patient's medical history, medical treatments, vaccinations and family history were not provided.   Concomitant vaccinations included HEPATITIS A VACCINE (HEPATITIS A) and INFLUENZA VACCINE INACT SPLIT 3V (FLUARIX) for prophylactic vaccination on 23-Aug-2020.  On 23-Aug-2020, the patient received a dose of DIPHTHERIA-15/TETANUS/5 HYBRID AC PERTUSSIS/IPV (MRC5) VACCINE(Lot number- C5688AA, expiration date- 26-Nov-2021) via unknown route in unknown administration site for prophylactic vaccination .  It was a case of actual medication error due to Inappropriate age at vaccine administration (Latency: Same day).  At the time of report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Information has been received from a physician concerning a 6 year old patient who on 19-JAN-2001 was vaccinated with Varivax, 0.5 mL once. On 08-MAR-2006 the patient had a breakthrough case of chickenpox lesions. The patient's outcome was not reported. Additional information has been requested.
patient had swelling of left eyelid and itching.  Administered 50mg IM Bendaryl
Right arm huritng; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Right arm huritng) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Right arm huritng). At the time of the report, PAIN IN EXTREMITY (Right arm huritng) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: Non-significant follow-up
This spontaneous case reported by a consumer, describes the occurrence of pain in extremity (sore arm) in a 92-year-old patient, of an unknown gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced pain in extremity (sore arm). At the time of the report, pain in extremity (sore arm) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medication or treatment information provided. This case linked to MOD-2021-117720 (patient link).
Client is a 16 year old male who came in for his second dose of Pfizer. Client received a pediatric formulation dose. Client notified before leaving the clinic. No other adverse symptoms to report at this time.
Very dizzy, poss. increased (0928) heart rate. Legs today are "very rubbery". No dizziness today (9-29)
Breakthrough case admission after 2 vaccines Moderna 3/5/21 Lot# 030A21A;  Moderna 4/12/21 Lot# 025b21A
Pt got severe bruising around site of injection (+) hard welt at injection site. It decreased range of movement x 2 days. Now improving. It is on right arm.
Ran high fevers of 102 x4 days,  followed by increasing muscle pain and weakness as well as fatigue. The following months the muscles in my upper arms and bilateral hips and thighs has deteriorating. It feels like I have been lifting 1000 lbs over and over with intense fatigue. To the point I cannot even hold my cellphone at times. I ache like I have the flu by end of the day. I have had several incidents of spontaneous loss of bladder control that I have never had before. It feels like my muscles are eating themselves and all I can do is cry. I am experiencing uncontrolled muscle spasms of same muscles. It has significantly impacted my balance and resulting in multiple falls. This all started after receiving moderna vaccines. The problems are increasing not getting better.
Allergic reaction within 10 sec.  Tongue swelled, lips swelled, tingly tightness in throat and down center of chest/digestive, tingly tightness across my shoulders.  1 Hour.    Per the Center, they phoned Moderna and Benedryl 25 mg was taken.  I took another 25 mg a few hours later.    In addition, I went to my immunologist for follow up (9 days after Moderna Vaccine 1 reaction on 01/16/2021).  He cleared my taking my monthly allergy injections.  I had a worse reaction to that and never do.  The Moderna Vaccine was in my system.  Same symptoms but my lips swelled further, broke out in hives on chest, oxygen level fell to 91.
Swelling and redness (L) thigh secondary to DPT reaction. Rx prednisone 18 m daily x 5 days. Cephalexin 250 m bid x 10d. Avoid pertussis vaccine in future.
Soreness at the injection site; I had itchiness and redness in the crook of my arm.  The left arm was worse than the right (I got my shot in my left arm); I had itchiness and redness in the crook of my arm.  The left arm was worse than the right (I got my shot in my left arm); This is a spontaneous report from a contactable consumer (patient). A 66-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in left arm on 23Feb2021 at 18:45 (Batch/Lot Number: EN6202) (at the age of 66-years-old) as dose 1, single for COVID-19 immunisation. Medical history included osteopenia (the reason why patient took vitamin D and calcium). The patient was not pregnant at time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. The patient had no known allergies. Concomitant medications included calcium and vitamin D NOS, taken for osteopenia, start and stop dates were not reported; ibuprofen, taken for an unspecified indication, start and stop dates were not reported. The patient did not receive any other vaccines within 4 weeks prior to vaccination. The patient experienced itchiness and redness in the crook of her arm, the left arm was worse than the right (she got her shot in her left arm) on 23Feb2021 at 19:30. It disappeared within an hour to 1 1/2 hours. The following day, soreness at the injection site on 24Feb2021. The patient received no treatment for the events. The adverse events resulted to none. The outcome of events itchiness and redness in the crook of her arm was recovered on 23Feb2021; while event soreness at the injection site recovered on an unspecified date.  No follow-up attempts are possible. No further information is expected.
flush; my lips and tongue started to tingle; my nose started to get itchy; my throat feels like it's closing; This is a spontaneous report from a contactable consumer (patient). A 52-year-old non-pregnant female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot Number: ER8731), dose 2 via an unspecified route of administration, administered in Arm Left on 16Apr2021 18:15 (Age 52-year-old at the time of vaccination) as DOSE 2, SINGLE for covid-19 immunisation. Facility type vaccine included Hospital. The medical history included covid prior vaccination. The patient was tested for covid post vaccination. The patient had no known allergies. The did not have any other vaccine in four weeks. Concomitant medications taken in two weeks included levocetirizine dihydrochloride (Xyzal), MINERALS NOS, VITAMINS NOS (Centrum/ CENTRUM A TO ZINC), and naproxen sodium (Aleve) all taken for an unspecified indication, start and stop date were not reported. The historical vaccine included of BNT162B2 (Batch/Lot Number: ER8732) Dose 1 via an unspecified route of administration, administered in Arm Left on 25Mar2021 at 05:45 PM on Left arm as DOSE 1, SINGLE for covid-19 immunisation. The patient stated that, about 25-30 minutes after getting second dose, she started to get flush, her lips and tongue started to tingle on 16Apr2021 18:45. Then her nose started to get itchy, and her throat felt like it was closing on 16Apr2021 18:45. The patient was observing now, 2 hours after the vaccine. No treatment was received for the events. The patient underwent lab tests and procedures which included covid test post vaccination with a Nasal Swab. The Covid test name post vaccination was Sema4 SARS-CoV-2 Viral RNA on 17Jan2021, which was found to be Negative. The outcome of the event was reported as not recovered.  No follow up attempts are possible. No further information is expected.
This spontaneous report was received from a health care worker, referring to multiple unspecified patients of unknown age and gender.  Information about patients' medical history, concurrent conditions and concomitant medication were not reported. On unspecified dates, the patients were administered doses of improperly stored PROQUAD (lot # M011663, expiration date 08-SEP-2017; lot # M018637, expiration date: 11-OCT-2017) (dose and route were not provided) for prophylaxis. The temperature excursion was of 11F in a time frame of 30 minutes. Data logger was reported as Yes. No adverse effects were reported.  No product quality complaint was involved. This is one of the several reports received from the same reporter. On 13-DEC-2016, all telephone attempts to obtain follow-up information have been unsuccessful. Additional information has been requested. Sender's Comments: US-009507513-1610USA015290: US-009507513-1610USA015314: US-009507513-1610USA015315: US-009507513-1610USA015317: MERCK 1610USA015316:Mfr number.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 08Mar2021 as dose 1, single (Batch/Lot number: unknown), in left arm and on 29Mar2021 as dose 2, single (Batch/Lot number: unknown) at the age of 58 years, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Asa, reaction(s): "known allergies: ASA", notes: known allergies: ASA. It was unknown that patient took any other medications in 2 weeks. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of vaccination failure, covid-19.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
pt recv vax; dx w/ ear infect; placed on atb; later, suffered 2 sz and was seen in er;